These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8669925)

  • 1. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.
    Korinthenberg R; Mönting JS
    Arch Dis Child; 1996 Apr; 74(4):281-7. PubMed ID: 8669925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    Korinthenberg R; Schessl J; Kirschner J; Mönting JS
    Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome in childhood: natural course and efficacy of plasmapheresis.
    Jansen PW; Perkin RM; Ashwal S
    Pediatr Neurol; 1993; 9(1):16-20. PubMed ID: 8452594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome.
    Vajsar J; Sloane A; Wood E; Murphy EG
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1210-2. PubMed ID: 7921126
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood.
    al-Qudah AA
    J Child Neurol; 1994 Apr; 9(2):178-80. PubMed ID: 8006371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of plasmapheresis in childhood Guillain-Barré syndrome.
    Epstein MA; Sladky JT
    Ann Neurol; 1990 Jul; 28(1):65-9. PubMed ID: 2375635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
    Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmapheresis with acute inflammatory polyneuropathy.
    Khatri BO; Flamini JR; Baruah JK; Dobyns WB; Konkol RJ
    Pediatr Neurol; 1990; 6(1):17-9. PubMed ID: 2310433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome: a pediatric challenge.
    Delgado MR
    J Child Neurol; 1996 Jan; 11(1):1-3. PubMed ID: 8745377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis in children with Guillain-Barré syndrome.
    Lamont PJ; Johnston HM; Berdoukas VA
    Neurology; 1991 Dec; 41(12):1928-31. PubMed ID: 1745351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients.
    Hughes RA; Hadden RD; Rees JH; Swan AV
    Brain; 1998 Apr; 121 ( Pt 4)():767-9. PubMed ID: 9577400
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognosis in severe Guillain-Barré syndrome.
    Cole GF; Matthew DJ
    Arch Dis Child; 1987 Mar; 62(3):288-91. PubMed ID: 3566320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmapheresis and high-dose immunoglobulins in the treatment of acute demyelinating polyneuropathy].
    Marino A; Logi G; Roncucci P; Sodini ML; Fornaini F
    Minerva Anestesiol; 1993 Jun; 59(6):307-11. PubMed ID: 8414090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
    Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
    Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin as therapy for pediatric Guillain-Barré syndrome.
    Abd-Allah SA; Jansen PW; Ashwal S; Perkin RM
    J Child Neurol; 1997 Sep; 12(6):376-80. PubMed ID: 9309521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.